Legal Opinion

Board of Regents, The University of Texas System v. Boston Scientific Corporation

District Court, D. Delaware

Decided October 6, 2022No. 1:18-cv-00392Unknown

1Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM and TISSUEGEN, Inc. Plaintiffs, Civil Action No. 18-392-GBW V. BOSTON SCIENTIFIC Corp. Defendant. MEMORANDUM ORDER Plaintiffs TissueGen, Inc. (TissueGen) and the Board of Regents, The University of Texas System (collectively, “UT”) allege that Defendant Boston Scientific Corp.’s (“BSC”) “Synergy” brand coronary stents (the “Accused Products”) infringe claims 1, 11, 12, 17, and 26 (the “Asserted Claims”) of

U.S. Patent No. 6,596,296

(“the 296 patent”). D.I. 124 1-3, 79. Pending…

2Cases cited10 opinions

Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
Halo Electronics, Inc. v. Pulse Electronics, Inc.Supreme Court of the United States · 2016
Novosteel Sa v. United States, and Bethlehem Steel Corporation and U.S. Steel Group, a Unit of Usx Corporation (Now Known as United States Steel Llc)Court of Appeals for the Federal Circuit · 2002
Smithkline Beecham Corp. v. Apotex [Corrected Date]Court of Appeals for the Federal Circuit · 2006
Wbip, LLC v. Kohler Co.Court of Appeals for the Federal Circuit · 2016

5 more not listed; retrieve them via the Exa API.